Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Users Online: 998 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

EDUCATIONAL FORUM

Vaptans: A new option in the management of hyponatremia

Aditya Suruchi, Rattan Aditya

Year : 2012| Volume: 2| Issue : 2 | Page no: 77-83

   This article has been cited by
 
1 Hyponatraemia and hypernatraemia: Disorders of Water Balance in Neurosurgery
Mendel Castle-Kirszbaum,Mervyn Kyi,Christopher Wright,Tony Goldschlager,R. Andrew Danks,W. Geoffrey Parkin
Neurosurgical Review. 2021;
[Pubmed]  [Google Scholar] [DOI]
2 Tolvaptan Response in a Hyponatremic Newborn with Syndrome of Inappropriate Secretion of Antidiuretic Hormone
Cengiz Zeybek,Ali Dinç Bozat,Erhan Calisici,Ahmet Bolat,Belma Saygili Karagol,Carmelo Romeo
Case Reports in Pediatrics. 2021; 2021: 1
[Pubmed]  [Google Scholar] [DOI]
3 A Case Report of Severe Hyponatremia Secondary to Coronavirus Disease 2019 Viral Pneumonia
Vinati Pillutla,Anooj Patel,Sindhoora Koneru,Kenneth K Ng,Mitchell K Ng
Cureus. 2021;
[Pubmed]  [Google Scholar] [DOI]
4 Regulation of Serum Sodium Levels during Chemotherapy Using Selective Arginine Vasopressin V2-Receptor Antagonist Tolvaptan in a Four-Year-Old Girl with a Suprasellar Germ Cell Tumor
Shota Hiroshima,Hiromi Nyuzuki,Sunao Sasaki,Yohei Ogawa,Keisuke Nagasaki
Children. 2021; 8(4): 293
[Pubmed]  [Google Scholar] [DOI]
5 Modern trends in diuretics development
Tetiana Titko,Lina Perekhoda,Irina Drapak,Yevgen Tsapko
European Journal of Medicinal Chemistry. 2020; : 112855
[Pubmed]  [Google Scholar] [DOI]
6 Tolvaptan Use to Treat SIADH in a Child
Adem Yasin Koksoy,Meltem Kurtul,Asli Kantar Ozsahin,Fatma Semsa Cayci,Meltem Tayfun,Umut Selda Bayrakci
The Journal of Pediatric Pharmacology and Therapeutics. 2018; 23(6): 494
[Pubmed]  [Google Scholar] [DOI]
7 Effectiveness and Safety of Tolvaptan for the Management of Hyponatremia: Risk of Inadvertent Overcorrection
Anish ???,Anish Seoung Ju Park,Anish Heung-Bum Lee,Anish ???,Anish ???,Anish ???,Anish ???
Journal of Korean Society of Health-System Pharmacists. 2018; 35(4): 430
[Pubmed]  [Google Scholar] [DOI]
8 Characterization of the phase I and phase II metabolic profile of tolvaptan by in vitro studies and liquid chromatography–mass spectrometry profiling: Relevance to doping control analysis
Monica Mazzarino,Valeria Buccilli,Xavier de la Torre,Ilaria Fiacco,Amelia Palermo,Daniele Ughi,Francesco Botrè
Journal of Pharmaceutical and Biomedical Analysis. 2017;
[Pubmed]  [Google Scholar] [DOI]
9 Unveiling some FDA-approved drugs as inhibitors of the store-operated Ca2+ entry pathway
Saifur Rahman,Taufiq Rahman
Scientific Reports. 2017; 7(1)
[Pubmed]  [Google Scholar] [DOI]
10 Conivaptan, a Selective Arginine Vasopressin V1a and V2 Receptor Antagonist Attenuates Global Cerebral Edema Following Experimental Cardiac Arrest via Perivascular Pool of Aquaporin-4
Shin Nakayama,Mahmood Amiry-Moghaddam,Ole Petter Ottersen,Anish Bhardwaj
Neurocritical Care. 2016;
[Pubmed]  [Google Scholar] [DOI]
11 L’hyponatrémie chez le patient cérébrolésé en soins intensifs : étiologie et prise en charge
P. L. Langlois,M. J. Bourguignon,W. Manzanares
Réanimation. 2016;
[Pubmed]  [Google Scholar] [DOI]
12 Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic-refractory congestive heart failure: the SEMI-SEC project
Antonio Pose,Luis Almenar,Juan José Gavira,Amador López-Granados,Teresa Blasco,Juan Delgado,Oscar Aramburu,Avelino Rodríguez,Luis Manzano,Nicolás Manito
ESC Heart Failure. 2016;
[Pubmed]  [Google Scholar] [DOI]
13 Tolvaptan use during hyperhydration in paediatric intracranial lymphoma with SIADH
Ruben H Willemsen,Violeta Delgado-Carballar,Daniela Elleri,Ajay Thankamony,G A Amos Burke,James C Nicholson,David B Dunger
Endocrinology, Diabetes & Metabolism Case Reports. 2016;
[Pubmed]  [Google Scholar] [DOI]
14 Syndrome of Inappropriate Antidiuretic Hormone Secretion and Cerebral/Renal Salt Wasting Syndrome: Similarities and Differences
Ji Young Oh,Jae Il Shin
Frontiers in Pediatrics. 2015; 2
[Pubmed]  [Google Scholar] [DOI]
15 Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites?
Hiroshi Fukui
World Journal of Gastroenterology. 2015; 21(41): 11584
[Pubmed]  [Google Scholar] [DOI]
16 Hiponatremias en el paciente neurocrítico: enfoque terapéutico basado en la evidencia actual
W. Manzanares,I. Aramendi,P.L. Langlois,A. Biestro
Medicina Intensiva. 2015;
[Pubmed]  [Google Scholar] [DOI]
17 Hyponatremia in the neurocritical care patient: An approach based on current evidence
W. Manzanares,I. Aramendi,P.L. Langlois,A. Biestro
Medicina Intensiva (English Edition). 2015;
[Pubmed]  [Google Scholar] [DOI]
18 Outpatient management of chronic heart failure
Elisabeth Kaldara,Despina Sanoudou,Stamatis Adamopoulos,John N Nanas
Expert Opinion on Pharmacotherapy. 2015; 16(1): 17
[Pubmed]  [Google Scholar] [DOI]
19 Treatment of stroke related refractory brain edema using mixed vasopressin antagonism: a case report and review of the literature
Vishnumurthy Shushrutha Hedna,Sharathchandra Bidari,David Gubernick,Saeed Ansari,Irawan Satriotomo,Asif A Khan,Adnan I Qureshi
BMC Neurology. 2014; 14(1)
[Pubmed]  [Google Scholar] [DOI]
20 Role of vaptans in the management of hydroelectrolytic imbalance in liver cirrhosis
Antonio Facciorusso
World Journal of Hepatology. 2014; 6(11): 793
[Pubmed]  [Google Scholar] [DOI]

 

Read this article